What's New on the FDA Drugs Site
October 12, 2016
- CDER Statement: FDA Updates on Multistate Outbreak of Burkholderia cepacia Infections (update)
- Drug Approval Packages:
- Drug Firm Annual Registration Status Download File (updated)
- Drug Firm Annual Registration Status (updated)
- Drugs@FDA Data Files (updated)
- La FDA advierte sobre el riesgo de reactivación de la hepatitis B en algunos pacientes tratados con antivirales de acción directa para la hepatitis C
- FDA Public Workshop: Cardiovascular Toxicity Assessment in Oncology Trials (updated)
- Medication Guides Page (updated)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario